About Aamorb pharma
Aamorb pharma is a Healthcare company based in Indore (India) founded in 2006. It operates as a development and marketing of pharmaceuticals in therapeutic areas such as Alimentary and Respiratory. It operates in the Healthcare and Consumer sectors. Its Indian entity Aamorb Pharmaceuticals Private Limited reported revenue of ₹11.23 Cr. Aamorb pharma offers products and services including Analgesics and Antibiotics. Its focus areas include Pharmaceuticals, Drug Development, Therapeutic Medications and Personal Care Products.
Company details
Aamorb Pharmaceuticals Private Limited is recognized as an innovative national pharmaceutical company that develops and markets novel medications to address unmet medical needs in areas like Alimentary, Musculoskeletal, Endocrine, Central Nervous System, Respiratory, Allergy, Skin, Nutrition, and Metabolism. Products are offered in forms such as tablets, capsules, liquids, ointments, injections, soap, shampoo, nasal sprays, respules, and inhalers. The company operates divisions including St.Morison, Syrinx, Cliftas, and Ved Yogi, while adhering to standards of quality, safety, integrity, dignity, and responsibility. It is based in Indore, India, with 30 years of experience and a wide portfolio across 200 states or cities.
- Headquarters Indore, India
- SectorsHealthcareConsumer
- Email••••••••
- Social LinkedIn YouTube
- Legal Name Aamorb Pharmaceuticals Private Limited
- Date of Incorporation 29 Mar, 2006
- Jurisdiction Indore, Madhya Pradesh, India
- Annual Revenue₹11.23 Cr
FY 2025 · -38% YoY
- Net Profit₹10.7 Lakh
FY 2025 · 1% margin
- EBITDA₹34.4 Lakh
FY 2025 · 3% margin
Associated legal entities of Aamorb pharma
Aamorb pharma operates through Aamorb Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aamorb Pharmaceuticals Private Limited CIN U02423MP2006PTC018519 | Active | 29 Mar 2006 | Indore, Madhya Pradesh | ₹11.2 Cr | – | 2 | View details |
Products & Services of Aamorb pharma
Aamorb pharma offers a comprehensive portfolio of products and services, including Analgesics and Antibiotics.
Analgesics are developed and marketed for pain relief in various formulations.
Antibiotics are produced and distributed for treating infections across different delivery methods.
Apps and channels of Aamorb pharma
its YouTube channel SYRINX | Aamorb Pharmaceuticals Pvt Ltd has 4 subscribers.
Board of directors of Aamorb Pharmaceuticals Private Limited (Aamorb pharma)
Aamorb Pharmaceuticals Private Limited is the primary company behind Aamorb pharma. The board of Aamorb Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Mahesh Kumar Jaswani, appointed in 2006. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mahesh Kumar Jaswani DIN 00021603 | Director | 29 Mar 2006 | 20 yrs 6 mo | Aamorb Pharmaceuticals Private Limited |
| Tanishq Jaswani DIN 10385722 | Director | 10 Nov 2023 | 2 yrs 11 mo | Aamorb Pharmaceuticals Private Limited |
Financials of Aamorb pharma
Figures of Aamorb Pharmaceuticals Private Limited, the primary company behind Aamorb pharma, for FY 2025. Revenue was ₹11.23 Cr (-38% year on year). Net profit was ₹10.7 Lakh (1% margin). EBITDA was ₹34.4 Lakh (3% margin). Revenue has grown at a compounded annual rate of -22% over three years and -12% over five years.
- ₹11.23 CrRevenue · FY 2025 · -38% YoY
- ₹10.7 LakhNet profit · 1% margin
- ₹34.4 LakhEBITDA · 3% margin
- ₹20 LakhPaid-up capital
- -22%Revenue CAGR, 3 years
- -12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Aamorb Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Aamorb pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Aamorb pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aamorb pharma
Aamorb pharma was founded in 2006.
Aamorb pharma is headquartered in Indore, India. It is registered at Indore, Madhya Pradesh, India.
The primary company behind Aamorb pharma, Aamorb Pharmaceuticals Private Limited, reported revenue of ₹11.23 Cr for FY 2025, down 38% year on year.
Aamorb Pharmaceuticals Private Limited is recognized as an innovative national pharmaceutical company that develops and markets novel medications to address unmet medical needs in areas like Alimentary, Musculoskeletal, Endocrine, Central Nervous System, Respiratory, Allergy, Skin, Nutrition, and Metabolism. Products are offered in forms such as tablets, capsules, liquids, ointments, injections, soap, shampoo, nasal sprays, respules, and inhalers. The company operates divisions including St.Morison, Syrinx, Cliftas, and Ved Yogi, while adhering to standards of quality, safety, integrity, dignity, and responsibility. It is based in Indore, India, with 30 years of experience and a wide portfolio across 200 states or cities.
Aamorb pharma offers Analgesics and Antibiotics.
Aamorb pharma operates through Aamorb Pharmaceuticals Private Limited.
The legal entities of Aamorb pharma currently have 2 directors, including Tanishq Jaswani, Mahesh Kumar Jaswani.